Booster-Effect with Velaglucerase Alfa in Patients with Gaucher Disease Switched from Long-Term Imiglucerase Therapy: Early Access Program Results from Jerusalem

✍ Scribed by Deborah Elstein; Gheona Altarescu; Hannah Maayan; Mici Phillips; Aya Abrahamov; Irith Hadas-Halpern; Maayan Tiomkin; Ari Zimran

• Book ID: 116989540
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 71 KB
• Volume: 105
• Category: Article
• ISSN: 1096-7192
• DOI: 10.1016/j.ymgme.2011.11.054